Latest in NHS

Destiny Pharma receives US FDA QIDP designation for novel antibacterial product

Lead drug product in development for the prevention of post-surgical Staphyloccocal infections

Find out more

You need to be a subscriber to read this article.
Click here to find out more.

When validated systems lose trust: why cyber risk is a Pharma 5.0 safety issue

Pharma 5.0 depends on connected, data-rich manufacturing environments, but cybersecurity weaknesses can undermine the safety functions, control systems and validated data that...
See more

Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference

By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence